BACK TO TOP
KSE100
173,939.01
4027.06
(2.37%)
KSE100PR
53,622.88
1239.26
(2.37%)
ALLSHR
103,800.94
2426.33
(2.39%)
KSE30
52,809.96
1336.80
(2.60%)
KMI30
250,755.67
4699.36
(1.91%)
BKTI
48,513.81
1916.74
(4.11%)
OGTI
36,285.57
1083.83
(3.08%)
KMIALLSHR
67,535.39
1339.91
(2.02%)
PSXDIV20
80,093.00
1659.38
(2.12%)
UPP9
61,350.75
1207.70
(2.01%)
NITPGI
46,045.37
1004.65
(2.23%)
NBPPGI
50,501.66
1375.28
(2.80%)
MZNPI
30,945.29
655.33
(2.16%)
JSMFI
42,239.25
953.27
(2.31%)
ACI
23,294.35
556.51
(2.45%)
JSGBKTI
74,046.40
3027.28
(4.26%)
HBLTTI
18,242.28
16-04-2026
0.10
(0.00%)
MII30
22,636.82
365.22
(1.64%)
Citi Pharma Ltd.
PHARMACEUTICALS
Rs.87.65
5.49
(6.68%)
1D
1M
6M
YTD
1Y
3Y
5Y
^ As of Fri, Apr 17, 2026 4:49 PM
REG
DFC
CSF
ODL
Open
82.28
High
90.38
Low
82.28
Volume
6,266,835
CIRCUIT BREAKER
73.94 — 90.38
DAY RANGE
82.28 — 90.38
52-WEEK RANGE ^
60.50 — 104.25
Ask Price
0.00
Ask Volume
0
Bid Price
0.00
Bid Volume
0
LDCP
82.16
VAR
15.00
HAIRCUT
22.50
P/E Ratio (TTM) **
19.22
1-Year Change * ^
-9.11%
YTD Change * ^
3.61%
Last update: Fri, Apr 17, 2026 4:47 PM
Open
82.70
High
90.50
Low
82.70
Close
88.02
Change
6.73%
LDCP
82.47
Volume
1,243,000
Total Trades
925
CIRCUIT BREAKER
74.22 — 90.72
DAY RANGE
82.70 — 90.50
Ask Price
0.00
Ask Volume
0
Bid Price
0.00
Bid Volume
0
Last update: Sun, Feb 1, 2026 3:49 AM
Open
0.00
High
0.00
Low
0.00
Close
0.00
Change
0.00%
LDCP
82.43
Volume
0
Total Trades
0
CIRCUIT BREAKER
74.19 — 90.67
DAY RANGE
0.00 — 0.00
Ask Price
0.00
Ask Volume
0
Bid Price
0.00
Bid Volume
0
Last update: Sun, Mar 29, 2026 4:05 AM
Open
0.00
High
0.00
Low
0.00
Close
0.00
Change
0.00%
LDCP
84.57
Volume
0
Total Trades
0
CIRCUIT BREAKER
76.11 — 93.03
DAY RANGE
0.00 — 0.00
Ask Price
0.00
Ask Volume
0
Bid Price
0.00
Bid Volume
0
Last update: Sun, Mar 1, 2026 2:45 AM
Open
0.00
High
0.00
Low
0.00
Close
0.00
Change
0.00%
LDCP
83.62
Volume
0
Total Trades
0
CIRCUIT BREAKER
75.26 — 91.98
DAY RANGE
0.00 — 0.00
Ask Price
0.00
Ask Volume
0
Bid Price
0.00
Bid Volume
0

No record found

Market data powered by capitalstake.com. Provided by PSX. ** Based on unconsolidated financials
  * Returns not adjusted for payouts
  ^The historical stock prices have been adjusted to reflect stock splits to ensure comparability over time.

Company Profile

BUSINESS DESCRIPTION

Citi Pharma Limited incorporated as a private limited company in Pakistan under the repealed Companies Ordinance, 1984 on October 08, 2012. The principal activity of the company is manufacturing and sale of pharmaceuticals, medical chemicals and botanical products.

KEY PEOPLE
Rizwan AhmadCEO
Nadeem AmjadChairperson
Muhammad Rasheed AlamCompany Secretary
ADDRESS

3-KM, Head Balloki Road, Bhai Pheru, Distt Kasur

WEBSITE

www.citipharma.com.pk

REGISTRAR

F.D Registrar Services (Pvt.) Ltd.

AUDITOR

Aslam Malik & Co. Chartered Accountants

Fiscal Year End

June

Equity Profile

Market Cap (000's)
20,024,624.18
Shares
228,461,200
Free Float
114,230,600
Free Float
50.00%

Announcements

Financial Results
Board Meetings
Others
DateTitleDocument
Feb 18, 2026Transmission of Quarterly Financial Statements for the Period Ended 2025-12-31 View   PDF
Feb 13, 2026Financial Results for the Quarter Ended December 31, 2025 View   PDF
Oct 30, 2025TRANSMISSION OF QUARTERLY REPORT FOR THE PERIOD ENDED View   PDF
Oct 29, 2025Financial Results for the Quarter Ended View   PDF
Oct 7, 2025Transmission of Annual Report for the Year Ended View   PDF
DateTitleDocument
Feb 3, 2026Board meeting View   
Feb 3, 2026Board Meeting
REVOKED
View   
Nov 13, 2025Certified True Copy of the Resolutions Passed in the Annual General Meeting View   PDF
Oct 29, 2025Board Meeting Other Than Financial Results (Post Election BOD Meeting) View   
Oct 24, 2025Board Meeting View   
DateTitleDocument
Mar 30, 2026Disclosure of Interest by a Director CEO, or Executive of a listed company and their Spouses and the Substantial Shareholders u/c 5.6.1.(d) of PSX Regulations View   
Mar 17, 2026Appointment of Company Secretary View   
Mar 17, 2026Appointment of Chief Financial Officer View   
Mar 13, 2026Disclosure of Interest by a Director CEO, or Executive of a listed company and their Spouses and the Substantial Shareholders u/c 5.6.1.(d) of PSX Regulations View   
Mar 11, 2026Disclosure of Interest by a Director CEO, or Executive of a listed company and their Spouses and the Substantial Shareholders u/c 5.6.1.(d) of PSX Regulations View   

Financials

All numbers in thousands (000's) except EPS

Annual
Quarterly
2025202420232022
Sales13,153,52112,409,23912,396,9839,779,880
Profit after Taxation892,039833,464657,984635,884
EPS3.903.652.882.88
Q2 2026Q1 2026Q3 2025Q2 2025
Sales4,332,5663,370,2473,341,1083,534,432
Profit after Taxation404,334203,691220,375256,979
EPS1.770.890.961.12
Data powered by Capital Stake. To provide comparable data, information might have been standardized. The data presented may therefore differ from issuer's annual report and 'as reported' data should be obtained directly from the source issuer. See the Capital Stake Terms of Use.

Ratios

2025202420232022
Gross Profit Margin (%)15.3412.7812.1613.83
Net Profit Margin (%)6.786.725.316.50
EPS Growth (%)6.8526.74(20.88)
PEG3.140.29(0.54)

Payouts

Financial Reports